Skip to main content
Premium Trial:

Request an Annual Quote

Study Says Bioinformatics Market Will Be Saturated

Premium

FOSTER CITY, Calif.--The value of the bioinformatics market could exceed $1.5 billion by 2005, but its compound annual growth rate is expected to decline as segments of the market become saturated, according to a new study, "Bioinformatics, a Strategic Business Analysis," published by Front Line Strategic Management Consulting here. The study's definition of the bioinformatics market includes providers of data, enterprise systems, and analytical software. Front Line said it expects the compound annual growth rate in bioinformatics to decline between 2001 and 2005 as customer needs are addressed.

The report stated that demand for genomics data has outpaced supply until now. But it asserted that "new data suppliers will emerge in this market offering access to their proprietary data for a fee, charging a premium price for early access to data that is not available from other sources."

Filed under

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.